Erste Group downgraded Eli Lilly (LLY) to Hold from Buy. The company lowered its earnings forecast for 2025, says the firm, which expects the shares to trend sideways in the medium term.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- Eli Lilly Stock (LLY) Grows Despite U.K. Warnings to Pregnant Women Over Weight Loss Jabs
- Mizuho medical devices/diagnostic analysts hold analyst/industry conference call
- Camurus, Lilly enter collaboration pact for long-acting FluidCrystal incretins
- Eli Lilly’s (LLY) CFO to Participate in Goldman Sachs Health Conference
- Eli Lilly announces new Phase 1 data for LY4170156 at ASCO
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue